Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
01/1997
01/22/1997EP0754040A1 Rapamycin derivatives
01/22/1997EP0699187B1 Beta,beta-dimethyl-4-piperidineethanamine derivatives as inhibitors of the cholesterol biosynthesis
01/22/1997EP0656898B1 Pyridopyrimidinone antianginal agents
01/22/1997EP0550737B1 Controlled release verapamil tablet
01/22/1997CN1141059A P53-binding polypeptides and polynucleotides encoding same
01/22/1997CN1141043A Non-peptide tachykinin receptor antagonists
01/22/1997CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof
01/22/1997CN1140991A Compositions containing micronized nebivolol
01/21/1997US5596013 Inhibitors of phosphodiesterase type iv and production of tumor necrosis factor
01/21/1997US5596009 Fused benzeneoxyacetic acid derivatives
01/21/1997US5596006 Trisubstituted biphenyls
01/21/1997US5595993 Antischemic piperazinyl- and piperidinyl-cyclohexanes
01/21/1997US5595990 Treatment of cardiovascular disorders
01/21/1997US5595976 Tetrahydropyran compounds
01/21/1997US5595974 Batroxobin with heparin for cardiovascular disorders
01/21/1997US5595970 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
01/21/1997US5595872 Dna sequences, cells and expression vectors
01/21/1997CA2100918C Oxime derivative
01/21/1997CA2028235C Condensed purine derivatives
01/20/1997CA2181515A1 4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
01/16/1997WO1997001579A2 Somatostatin peptides
01/16/1997WO1997001569A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a
01/16/1997WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents
01/16/1997WO1997001551A1 Pyrazole compounds and pharmaceutical compositions
01/16/1997WO1997001549A1 Benzothiophene compounds
01/16/1997WO1997001540A1 Integrin receptor antagonists
01/16/1997WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
01/16/1997WO1997001353A1 Use of il-11 to treat inflammation
01/16/1997WO1997001335A1 Di- and trivalent small molecule selectin inhibitors
01/16/1997WO1996036318A3 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
01/16/1997DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system
01/16/1997CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents
01/16/1997CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a
01/16/1997CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
01/16/1997CA2220991A1 Benzothiophene compounds
01/16/1997CA2220554A1 Use of il-11 to treat inflammation
01/15/1997EP0753526A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
01/15/1997EP0753517A2 Amides and sulfonamides of benzylamines with heterocyclic substituents
01/15/1997EP0753312A1 Arteriosclerosis remedy
01/15/1997EP0753301A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics
01/15/1997EP0753300A1 Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man
01/15/1997EP0753298A1 Synergistic combination comprising an insulin sensitizer and a HMG-CoA reductase inhibitor for treating arteriosclerosis
01/15/1997EP0753004A1 Antagonists of endothelin receptors
01/15/1997EP0752994A1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING THEM
01/15/1997EP0752993A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
01/15/1997EP0752992A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same
01/15/1997EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
01/15/1997EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
01/15/1997EP0752988A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
01/15/1997EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
01/15/1997EP0752985A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
01/15/1997EP0752981A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
01/15/1997EP0752881A1 A novel brain endothelial cell protein and methods for its use
01/15/1997EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor
01/15/1997EP0752866A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders
01/15/1997EP0752861A1 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
01/15/1997EP0752859A1 Pharmaceutical composition containing a class iii antiarrhythmic agent and a class iv antiarrhythmic agent
01/15/1997EP0752858A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
01/15/1997EP0752854A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
01/15/1997EP0711172B1 Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions
01/15/1997CN1140455A Diastereomeric pure trifluoromethyl ketone peptide derivs. as inhibitors of human leukocyte elastase
01/15/1997CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE
01/15/1997CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase
01/15/1997CN1140174A Piperidine derivatives, process for preparation thereof and application thereof in therapeutics
01/15/1997CN1140167A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes
01/15/1997CN1140164A Antiarrhythmic and cardioprotective substituted indenoyiguanidines
01/15/1997CN1140072A Oral liquid for treating cardiovascular diseases
01/14/1997US5594154 5-amino-2-bromomethyl-2,4,6,7-tetramethyl-2,3-dihydrobenzo(b) furans
01/14/1997US5594144 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
01/14/1997US5594033 Cardiovascular disorders
01/14/1997US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present
01/14/1997US5594022 Carbamates
01/14/1997US5594019 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
01/14/1997US5594014 Indole derivatives as 5-HT1 agonists
01/14/1997US5594013 Polyvinylpyrrolidone and an acrylic polymer, slow release
01/14/1997US5594010 Treatment of hypertension and atheriosclerosis
01/14/1997US5593992 Cytokine inhibitors
01/14/1997US5593991 Imidazole compounds, use and process of making
01/14/1997US5593990 Methods and compositions for inhibition of angiogenesis
01/14/1997US5593982 Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
01/14/1997US5593975 Adenosine derivatives having A2 agonist activity
01/14/1997US5593884 Oncoprotein protein kinase
01/14/1997US5593876 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
01/14/1997US5593664 Polyamides, polyureas
01/14/1997CA2056814C Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity
01/09/1997WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
01/09/1997WO1997000691A1 Modulation of endothelial cell proliferation
01/09/1997WO1997000675A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
01/09/1997CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
01/09/1997CA2225401A1 Modulation of endothelial cell proliferation
01/09/1997CA2225277A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
01/08/1997EP0752419A2 Process for the preparation of N-substituted 4-ketoproline derivatives
01/08/1997EP0752249A2 Use of an angiotensin II antagonist and a benzofurane derivative having antiarithmic activity for the manufacture of a medicament for the treatment of cardiovascular disorders
01/08/1997EP0752005A1 Compacted nucleic acids and their delivery to cells
01/08/1997EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
01/08/1997EP0752002A1 Inhibition of arterial smooth muscle cell proliferation
01/08/1997EP0751992A1 Vascular endothelial growth factor 2
01/08/1997EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
01/08/1997EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
01/08/1997EP0751936A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor